Marco Salvetti

Pubblicazioni

Titolo Pubblicato in Anno
Treatment modifiers across different regimens of natalizumab treatment in MS: An Italian real-world experience NEUROTHERAPEUTICS 2024
Disentangling multiple sclerosis phenotypes through Mendelian disorders: A network approach MULTIPLE SCLEROSIS 2024
Co-existence of Myelin Oligodendrocyte Glycoprotien Antibody-associated Disease (MOGAD) and Spinocerebellar Ataxia type 1 (SCA1): A case report NEUROLOGICAL SCIENCES 2024
Serum neurofilament light chain levels correlate with small fiber related parameters in patients with hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN) NEUROLOGICAL SCIENCES 2024
Case report: A novel mutation of glial fibrillary acidic protein gene causing juvenile-onset Alexander disease FRONTIERS IN NEUROLOGY 2024
Muscle MRI as a biomarker of disease activity and progression in myotonic dystrophy type 1: a longitudinal study JOURNAL OF NEUROLOGY 2024
EBV infection drives MS pathology: Yes MULTIPLE SCLEROSIS 2024
Gut Microbiota Composition Is Causally Linked to Multiple Sclerosis: A Mendelian Randomization Analysis MICROORGANISMS 2024
Clinical and Immunological Impact of Ocrelizumab Extended Interval Dosing in Multiple Sclerosis: A Single-Center, Real-World Experience INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2024
Cytomegalovirus, Epstein-Barr Virus, Herpes Simplex Virus, and Varicella Zoster Virus Infection Dynamics in People with Multiple Sclerosis from Northern Italy PATHOGENS 2024
Exploring miRNAs' based modeling approach for predicting PIRA in multiple sclerosis. A comprehensive analysis INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2024
Long-Term Follow-Up before and during Riluzole Treatment in Six Patients from Two Families with Spinocerebellar Ataxia Type 7 THE CEREBELLUM 2024
Safety and clinical effectiveness of peginterferon beta-1a for relapsing multiple sclerosis in a real-world setting: Final results from the Plegridy Observational Program MULTIPLE SCLEROSIS JOURNAL, EXPERIMENTAL, TRANSLATIONAL AND CLINICAL 2024
Peripheral Biomarkers in Manifest and Premanifest Huntington’s Disease INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2023
Sars-CoV2 infection in pregnant women with multiple sclerosis MULTIPLE SCLEROSIS 2023
Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: Who gains from it? EUROPEAN JOURNAL OF NEUROLOGY 2023
Frailty and relapse activity in multiple sclerosis: A longitudinal observation MULTIPLE SCLEROSIS AND RELATED DISORDERS 2023
Comparison of quantitative muscle ultrasound and whole-body muscle MRI in facioscapulohumeral muscular dystrophy type 1 patients NEUROLOGICAL SCIENCES 2023
Quantitative sensory testing and skin biopsy findings in late‐onset ATTRv pre‐symptomatic carriers: relationships with predicted time of disease onset (PADO) JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 2023
The value of Interferon β in multiple sclerosis and novel opportunities for its anti-viral activity: a narrative literature review FRONTIERS IN IMMUNOLOGY 2023

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma